One-and-Done Heart Disease Prevention? Scientists Show It May Be Possible.
A single infusion of an experimental gene-editing drug seemed to reduce LDL long-term in a small trial. The results may point to something “curative,” one expert said.
Researchers have demonstrated promising results in a small clinical trial for a novel gene-editing drug designed to combat heart disease. A single infusion of the experimental therapy appeared to significantly lower LDL cholesterol levels over an extended period. This approach, targeting the root cause of high cholesterol, offers a potential long-term solution for individuals at risk.
This development could revolutionize heart disease prevention by offering a potentially curative, one-time treatment instead of ongoing medication.
📌 Kaynak
Bu özet NYT Science kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →